Drug maker AFT Pharmaceuticals has had another breakthrough in the lucrative US market with approval for the sale of its intravenous Maxigesic pain relief medicine by the Food and Drug Administration.
Anan Zaki has the business news.
18 Oct 2023
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
